---
title: "Shandong Road and Bridge released its 2024 annual performance, with a net profit attributable to the parent company of 2.322 billion yuan, a year-on-year increase of 1.47%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/235901120.md"
description: "Shandong Road and Bridge announced its 2024 annual performance, with operating revenue of 71.348 billion yuan, a year-on-year decrease of 2.29%; net profit attributable to shareholders of the parent company was 2.322 billion yuan, a year-on-year increase of 1.47%; net profit excluding non-recurring gains and losses was 2.156 billion yuan, a year-on-year increase of 6.90%; basic earnings per share were 1.2281 yuan, and it plans to distribute a cash dividend of 1.7 yuan (including tax) for every 10 shares"
datetime: "2025-04-14T14:55:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235901120.md)
  - [en](https://longbridge.com/en/news/235901120.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235901120.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/235901120.md) | [繁體中文](https://longbridge.com/zh-HK/news/235901120.md)


# Shandong Road and Bridge released its 2024 annual performance, with a net profit attributable to the parent company of 2.322 billion yuan, a year-on-year increase of 1.47%

According to the Zhitong Finance APP, Shandong Road and Bridge (000498.SZ) released its annual report for 2024. The company's operating revenue for 2024 was 71.348 billion yuan, a year-on-year decrease of 2.29%; the net profit attributable to shareholders of the listed company was 2.322 billion yuan, a year-on-year increase of 1.47%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 2.156 billion yuan, a year-on-year increase of 6.90%; the basic earnings per share were 1.2281 yuan/share. It is proposed to distribute a cash dividend of 1.7 yuan (tax included) for every 10 shares

### 相关股票

- [SDRB (000498.CN)](https://longbridge.com/zh-CN/quote/000498.CN.md)

## 相关资讯与研究

- [Tajikistan Approves Hebei Changsha Biochemical Pharmaceutical's Thrombosis Injection](https://longbridge.com/zh-CN/news/278372421.md)
- [Pizu Group Details Tajikistan Mining Loan Deal and Planned 45% Stake in Kanzi Diyor](https://longbridge.com/zh-CN/news/278384508.md)
- [TAKE A LOOK-How the Iran war has rippled across global markets](https://longbridge.com/zh-CN/news/278400496.md)
- [Kyodo: N. Korea-China Rail Link Set to Restart for First Time in Six Years](https://longbridge.com/zh-CN/news/278489962.md)
- [CATL and Rio Tinto target electrification of mining operations](https://longbridge.com/zh-CN/news/278348983.md)